Klaus Giersiepen1, Hans-Werner Hense, Stefanie J Klug
1Bremer Institut für Präventionsforschung und Sozialmedizin (BIPS). giersiep@bips.uni-bremen.de
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Cancer screening programs require robust evidence of mortality reduction, ideally from randomized controlled trials. Effective cancer screening must include monitoring and address potential adverse effects for optimal public health impact.
Area of Science:
Context:
Purpose:
Summary:
Impact: